Status:
TERMINATED
Collecting and Storing Blood and Tumor Tissue Samples From Patients Undergoing Prostatectomy or Transurethral Resection of the Prostate
Lead Sponsor:
Rutgers, The State University of New Jersey
Collaborating Sponsors:
National Cancer Institute (NCI)
Rutgers Cancer Institute of New Jersey
Conditions:
Prostate Cancer
Eligibility:
MALE
18+ years
Brief Summary
The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, seru...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Undergoing routine prostatectomy or transurethral resection of the prostate (TURP)
- PATIENT CHARACTERISTICS:
- 1.1 Patient is undergoing routine prostatectomy or TURP.
- 1.2 Patient is ≥ 18 years old.
- 1.3 Patient must give informed consent.
- PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Exclusion
Key Trial Info
Start Date :
December 12 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 10 2017
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT00991315
Start Date
December 12 2008
End Date
April 10 2017
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States, 08903